Page last updated: 2024-11-13

o-acetyl-adp-ribose

Description Research Excerpts Clinical Trials Roles Classes Pathways Study Profile Bioassays Related Drugs Related Conditions Protein Interactions Research Growth Market Indicators

Description

O-Acetyl-ADP-Ribose: An acetyl ester of ADENOSINE DIPHOSPHATE RIBOSE formed during NAD-dependent deacetylation of proteins by SIRTUINS. The acetate group resides on the ribose ring where nicotinamide was cleaved from NAD during the reaction. Several isomers of O-acetyl-ADP-ribose have been isolated from the reaction. [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]

2''-O-acetyl-ADP-D-ribose : A nucleotide-sugar having ADP as the nucleotide fragment and 2-O-acetyl-D-ribofuranos-5-yl as the sugar component. [Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

Cross-References

ID SourceID
PubMed CID72193709
CHEBI ID76279
MeSH IDM0384443

Synonyms (15)

Synonym
AC1MMT9E ,
2''-o-acetyl-adp-ribose
C20658
aadpr
o-acetyl-adp-ribose
gtpl6333
[(3r,4r,5r)-5-[[[[(2r,3s,4r,5r)-5-(6-aminopurin-9-yl)-3,4-dihydroxyoxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-hydroxyphosphoryl]oxymethyl]-2,4-dihydroxyoxolan-3-yl] acetate
adenosine 5'-[3-(2-o-acetyl-d-ribofuranos-5-o-yl) dihydrogen diphosphate]
2'-o-acetyl-adp-ribose
oaadpr
2''-o-acetyl-adp-d-ribose
CHEBI:76279
2'-oaadpr
BFNOPXRXIQJDHO-YDKGJHSESA-N
o-acetyl-adp ribose
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Drug Classes (1)

ClassDescription
nucleotide-sugar
[compound class information is derived from Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

Pathways (33)

PathwayProteinsCompounds
Organelle biogenesis and maintenance23216
Mitochondrial biogenesis668
Transcriptional activation of mitochondrial biogenesis357
DNA Repair25547
DNA Double-Strand Break Repair10313
Homology Directed Repair839
HDR through Homologous Recombination (HRR) or Single Strand Annealing (SSA)799
Processing of DNA double-strand break ends518
Signaling Pathways1269117
Signaling by NOTCH11314
Pre-NOTCH Expression and Processing2413
Pre-NOTCH Transcription and Translation174
Cellular responses to stimuli48356
Cellular responses to stress46954
Cellular response to heat stress709
Regulation of HSF1-mediated heat shock response577
Cell Cycle53831
Cell Cycle, Mitotic41031
M Phase27921
Mitotic Metaphase and Anaphase15812
FOXO-mediated transcription607
Regulation of FOXO transcriptional activity by acetylation85
Mitotic Anaphase15712
Nuclear Envelope (NE) Reassembly5110
Initiation of Nuclear Envelope (NE) Reformation147
Gene expression (Transcription)90249
RNA Polymerase II Transcription72842
Generic Transcription Pathway60839
Epigenetic regulation of gene expression11717
Negative epigenetic regulation of rRNA expression456
SIRT1 negatively regulates rRNA expression95
NAD+ Signalling Pathway (Cancer)1012
The impact of Nsp14 on metabolism (COVID-19 Disease Map)084

Bioassays (1)

Assay IDTitleYearJournalArticle
AID1346628Human TRPM2 (Transient Receptor Potential channels)2006The Journal of biological chemistry, May-19, Volume: 281, Issue:20
Metabolite of SIR2 reaction modulates TRPM2 ion channel.
[information is prepared from bioassay data collected from National Library of Medicine (NLM), extracted Dec-2023]

Research

Studies (39)

TimeframeStudies, This Drug (%)All Drugs %
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's22 (56.41)29.6817
2010's16 (41.03)24.3611
2020's1 (2.56)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Market Indicators

Research Demand Index: 21.72

According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be moderate demand-to-supply ratio for research on this compound.

MetricThis Compound (vs All)
Research Demand Index21.72 (24.57)
Research Supply Index3.69 (2.92)
Research Growth Index6.11 (4.65)
Search Engine Demand Index18.60 (26.88)
Search Engine Supply Index2.00 (0.95)

This Compound (21.72)

All Compounds (24.57)

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials0 (0.00%)5.53%
Reviews7 (17.95%)6.00%
Case Studies0 (0.00%)4.05%
Observational0 (0.00%)0.25%
Other32 (82.05%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]